• Comorbidities in ADHD children treated with methylphenidate: a database study.

      Kraut, Angela A; Langner, Ingo; Lindemann, Christina; Banaschewski, Tobias; Petermann, Ulrike; Petermann, Franz; Mikolajczyk, Rafael; Garbe, Edeltraut; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany. (2013)
      Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorder (ADHD) in children. Treatment with MPH is contraindicated in the presence of certain psychiatric, cerebro- and cardiovascular conditions. We assessed MPH treatment prevalence and incidence and the frequency of comorbid conditions related to these contraindications in new MPH users compared to a control group without ADHD and ADHD medication.